XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities:    
Net loss $ (25,649,906) $ (18,093,349)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,929,279 993,114
Issuance of common stock for services 273,884 68,000
Amortization of operating lease right-of-use asset 131,235 121,339
Depreciation 2,192 761
Changes in operating assets and liabilities:    
Prepaid expenses (48,915) (1,149,158)
Deposits 19,031
Accounts payable 413,425 (501,571)
Accrued expenses 679,239 202,696
Accrued compensation (628,499) (115,106)
Accrued interest (87,996)
Operating lease liability (130,686) (117,145)
Net Cash Used In Operating Activities (22,028,752) (18,659,384)
Cash Flows From Investing Activities:    
Purchase of property and equipment (6,938)
Net Cash Used In Investing Activities (6,938)
Cash Flows From Financing Activities:    
Principal paid on notes payable – related parties (172,970)
Proceeds from sale of NoveCite, Inc. common stock 500
Net proceeds from private placement 18,450,410
Net proceeds from registered direct offering 70,979,842
Net proceeds from common stock warrant exercises 31,130,134
Net proceeds from common stock option exercises 82,634
Net Cash Provided By Financing Activities 120,470,550
Net Change in Cash and Cash Equivalents (22,028,752) 101,804,228
Cash and Cash Equivalents - Beginning of Period 70,072,946 13,859,748
Cash and Cash Equivalents - End of Period $ 48,044,194 $ 115,663,976